Financing Enables Cannabinoid Innovator to Continue Phase I-II Trials Of Numerous Intellectual Property (IP) Protected Cannabinoid-Based Products for Multiple Indications SAN DIEGO, CA– AXIM, MJNA, (Marketwired – October 26, 2016) – Medical Marijuana, Inc. (OTC PINK: MJNA) today announced that its portfolio company AXIM® Biotechnologies, Inc. (AXIM® Biotech) (OTC: AXIM), a world leader in cannabinoid research and development, has secured private funding to continue its pharmaceutical clinical trials program in cannabinoid research and development for multiple indications. AXIM® Biotech’s mostRead more
- NASCAR Superstar Denny Hamlin Partners with Chanticleer Holdings to Open Little Big Burger Location in Cornelius, N.C.
- How to Choose the Right Cryptocurrency to Invest in 2018
- mCig’s Subsidiary, Grow Contractors Inc., Announces it has Secured an Exclusive Management Contract in Sacramento, CA, Paving the Way to an Expanded Presence in the State
- MoneyTV with Donald Baillargeon, 4/20
- Alternate Health Launches First Complete Ethereum Blockchain EMR / EHR
SMALL CAP MARKET NEWS
We release small market news updates daily, 5 times a week! Always check back to get the inside scoop on what going on.
LEVERAGE OUR MASSIVE INVESTOR AUDIENCE!
Stock Investors · Accredited Investors · Hedge Fund InvestorsLearn More